✉  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

eClinical Solution Market Research Report Information By Type (Clinical Data Management System (CDMS), Randomization and Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (eCOA), and Clinical Trial Management System (CTMS)), By Delivery Mode (Web-Based, Cloud-Based, and Enterprise-based), By Clinical Trial Phase (Phase I, Phase II, and Phase III), By End Users (Contract Research Organizations (CROs), Pharma/Biotech Companies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast T


ID: MRFR/HCIT/1687-CR | 104 Pages | Author: Rahul Gotadki| May 2019

Market Segmentation


EClinical Solutions Type Outlook (USD Billion, 2019-2030)




  • Clinical Data Management System (CDMS)




  • Randomization and Trial Supply Management (RTSM)




  • Electronic Clinical Outcome Assessment (eCOA)




  • Clinical Trial Management System (CTMS)




EClinical Solutions Delivery Mode Outlook (USD Billion, 2019-2030)




  • Web-Based




  • Cloud-Based




  • Enterprise-based




EClinical Solutions Clinical Trial Phase Outlook (USD Billion, 2019-2030)




  • Phase I




  • Phase II




  • Phase III




EClinical Solutions End User Outlook (USD Billion, 2019-2030)




  • Contract Research Organizations (CROs)




  • Pharma/Biotech Companies




EClinical Solutions Regional Outlook (USD Billion, 2019-2030)




  • North America Outlook (USD Billion, 2019-2030)




    • North America EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • North America EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • North America EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • North America EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • US Outlook (USD Billion, 2019-2030)




    • US EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • US EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • US EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • US EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • CANADA Outlook (USD Billion, 2019-2030)




    • CANADA EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • CANADA EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • CANADA EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • CANADA EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies








  • Europe Outlook (USD Billion, 2019-2030)




    • Europe EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Europe EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Europe EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Europe EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Germany Outlook (USD Billion, 2019-2030)




    • Germany EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Germany EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Germany EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Germany EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • France Outlook (USD Billion, 2019-2030)




    • France EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • France EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • France EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • France EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • UK Outlook (USD Billion, 2019-2030)




    • UK EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • UK EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • UK EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • UK EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • ITALY Outlook (USD Billion, 2019-2030)




    • ITALY EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • ITALY EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • ITALY EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • ITALY EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • SPAIN Outlook (USD Billion, 2019-2030)




    • Spain EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Spain EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Spain EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Spain EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Rest of Europe Outlook (USD Billion, 2019-2030)




    • Rest of Europe EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • REST OF EUROPE EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • REST OF EUROPE EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • REST OF EUROPE EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies








  • Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Asia-Pacific EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Asia-Pacific EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Asia-Pacific EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Asia-Pacific EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • China Outlook (USD Billion, 2019-2030)




    • China EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • China EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • China EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • China EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Japan Outlook (USD Billion, 2019-2030)




    • Japan EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Japan EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Japan EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Japan EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • India Outlook (USD Billion, 2019-2030)




    • India EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • India EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • India EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • India EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Australia Outlook (USD Billion, 2019-2030)




    • Australia EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Australia EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Australia EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Australia EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)




    • Rest of Asia-Pacific EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Rest of Asia-Pacific EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Rest of Asia-Pacific EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Rest of Asia-Pacific EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies








  • Rest of the World Outlook (USD Billion, 2019-2030)




    • Rest of the World EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Rest of the World EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Rest of the World EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Rest of the World EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Middle East Outlook (USD Billion, 2019-2030)




    • Middle East EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Middle East EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Middle East EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Middle East EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Africa Outlook (USD Billion, 2019-2030)




    • Africa EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Africa EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Africa EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Africa EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies






    • Latin America Outlook (USD Billion, 2019-2030)




    • Latin America EClinical Solutions by Type




      • Clinical Data Management System (CDMS)




      • Randomization and Trial Supply Management (RTSM)




      • Electronic Clinical Outcome Assessment (eCOA)




      • Clinical Trial Management System (CTMS)






    • Latin America EClinical Solutions Delivery Mode




      • Web-Based




      • Cloud-Based




      • Enterprise-based






    • Latin America EClinical Solutions by Clinical Trial Phase




      • Phase I




      • Phase II




      • Phase III






    • Latin America EClinical Solutions by End User




      • Contract Research Organizations (CROs)




      • Pharma/Biotech Companies










Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Executive Summary

1.1 Market Attractiveness Analysis 15

2 Market Introduction

2.1 Definition 19

2.2 Scope Of The Study 19

2.3 Assumptions 19

2.4 Market Structure 19

3 Research Methodology

3.1 Research Process 20

3.2 Primary Research 21

3.3 Secondary Research 22

3.4 Market Size Estimation 23

3.5 Forecast Model 23

4 Market Dynamics

4.1 Introduction 24

4.2 Drivers 25

4.2.1 Increasing R&D Activities By Biopharmaceutical And Pharmaceutical Companies 25

4.2.2 Growing Expenditure In The Development Of Clinical Trials 25

4.2.3 Rising Burden Of Chronic Diseases 25

4.2.4 Increased Use Of Smart Devices For Healthcare Management 26

4.3 Restraints 26

4.3.1 Shortage Of Healthcare Professionals And Patients For Clinical Trials 26

4.3.2 Security And Confidentiality Of Data 26

4.4 Opportunities 27

4.4.1 Increasing R&D For Precision Medicine Will Strengthen The Market For EClinical Solutions 27

4.5 Mega Trends 27

5 Market Factor Analysis

5.1 Value Chain Analysis 28

5.1.1 Inputs 28

5.1.2 Software Development Process 29

5.1.3 Output 29

5.1.4 Marketing And Distribution 29

5.1.5 Post-Selling Services 29

5.2 Porter’s Five Forces Model 30

5.2.1 Threat Of New Entrants 30

5.2.2 Bargaining Power Of Suppliers 31

5.2.3 Bargaining Power Of Buyers 31

5.2.4 Threat Of Substitutes 31

5.2.5 Intensity Of Rivalry 31

5.3 Regulatory Framework 32

6 Global EClinical Solutions Market, By Type

6.1 Introduction 33

6.2 Clinical Data Management System (CDMS) 35

6.3 Randomization And Trial Supply Management (RTSM) 36

6.4 Electronic Clinical Outcome Assessment (ECOA) 37

6.5 Clinical Trial Management System (CTMS) 38

6.6 Electronic Trail Master Files (ETMF) 39

6.7 Trial Safety & Regulatory 40

7 Global EClinical Solutions Market, By Delivery Mode

7.1 Introduction 41

7.2 Web Based And Cloud Based 43

7.3 Enterprise Based 44

8 Global EClinical Solutions Market, By Clinical Trial Phase

8.1 Introduction 45

8.2 Phase I 46

8.3 Phase II 47

8.4 Phase III 48

8.5 Phase IV 49

9 Global EClinical Solutions Market, By End User

9.1 Introduction 50

9.2 Contract Research Organizations (CROs) 51

9.3 Pharma/Biotech Companies 52

10 Global EClinical Solutions Market, By Region

10.1 Introduction 53

10.2 Americas 56

10.2.1 North America 59

10.2.1.1 US 63

10.2.1.2 Canada 65

10.2.2 Latin America 68

10.3 Europe 71

10.3.1 Western Europe 74

10.3.1.1 Germany 77

10.3.1.2 UK 79

10.3.1.3 France 81

10.3.1.4 Italy 83

10.3.1.5 Spain 85

10.3.1.6 Rest Of Western Europe 87

10.3.2 Eastern Europe 89

10.4 Asia-Pacific 92

10.4.1 Japan 95

10.4.2 China 97

10.4.3 India 99

10.4.4 Australia 101

10.4.5 South Korea 103

10.4.6 Rest Of Asia-Pacific 105

10.5 Middle East & Africa 108

10.5.1 Middle East 111

10.5.2 Africa 113

11 Competitive Landscape

11.1 Company Market Share Analysis 115

11.1.1 Introduction 115

12 Company Profiles

12.1 ERT Clinical 117

12.1.1 Company Overview 117

12.1.2 Financial Overview 117

12.1.3 Products/Services Offered 117

12.1.4 Key Developments 118

12.1.5 SWOT Analysis 118

12.1.6 Key Strategies 118

12.2 Parexel International Corporation 119

12.2.1 Company Overview 119

12.2.2 Financial Overview 119

12.2.3 Products/Services Offered 120

12.2.4 Key Developments 120

12.2.5 SWOT Analysis 120

12.2.6 Key Strategies 121

12.3 BioClinica, Inc. 122

12.3.1 Company Overview 122

12.3.2 Financial Overview 122

12.3.3 Products/Services Offered 122

12.3.4 Key Developments 123

12.3.5 SWOT Analysis 123

12.3.6 Key Strategies 123

12.4 CRF Health 124

12.4.1 Company Overview 124

12.4.2 Financial Overview 124

12.4.3 Products/Services Offered 124

12.4.4 Key Developments 124

12.4.5 SWOT Analysis 125

12.4.6 Key Strategies 125

12.5 Oracle Corporation 126

12.5.1 Company Overview 126

12.5.2 Financial Overview 126

12.5.3 Products/Services Offered 127

12.5.4 Key Developments 127

12.5.5 SWOT Analysis 127

12.5.6 Key Strategies 127

12.6 Datatrak Int. 128

12.6.1 Company Overview 128

12.6.2 Financial Overview 128

12.6.3 Products/Services Offered 128

12.6.4 Key Developments 128

12.6.5 SWOT Analysis 129

12.6.6 Key Strategies 129

12.7 Merge Healthcare Inc. 130

12.7.1 Company Overview 130

12.7.2 Financial Overview 130

12.7.3 Products/Services Offered 131

12.7.4 Key Developments 131

12.7.5 SWOT Analysis 132

12.7.6 Key Strategies 132

12.8 Medidata Solutions, Inc. 133

12.8.1 Company Overview 133

12.8.2 Financial Overview 133

12.8.3 Products/Services Offered 134

12.8.4 Key Developments 134

12.8.5 SWOT Analysis 135

12.8.6 Key Strategies 135

12.9 Omnicomm Systems, Inc. 136

12.9.1 Company Overview 136

12.9.2 Financial Overview 136

12.9.3 Products/Services Offered 137

12.9.4 Key Developments 137

12.9.5 SWOT Analysis 138

12.9.6 Key Strategies 138

12.10 MaxisIT 139

12.10.1 Company Overview 139

12.10.2 Financial Overview 139

12.10.3 Products Offering 139

12.10.4 Key Developments 139

12.10.5 SWOT Analysis 140

12.10.6 Key Strategies 140

13 Appendix

13.1 References 141

13.2 Related Reports 141

14 List Of Tables

TABLE 1 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 34

TABLE 2 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL DATA MANAGEMENT SYSTEM (CDMS), BY REGION, 2020–2027 (USD MILLION) 35

TABLE 3 GLOBAL ECLINICAL SOLUTIONS MARKET FOR RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT (RTSM), BY REGION, 2020–2027 (USD MILLION) 36

TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC CLINICAL OUTCOME ASSESSMENT (ECOA), BY REGION, 2020–2027 (USD MILLION) 37

TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CLINICAL TRIAL MANAGEMENT SYSTEM (CTMS), BY REGION, 2020–2027 (USD MILLION) 38

TABLE 6 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ELECTRONIC TRAIL MASTER FILES (ETMF), BY REGION, 2020–2027 (USD MILLION) 39

TABLE 7 GLOBAL ECLINICAL SOLUTIONS MARKET FOR TRIAL SAFETY & REGULATORY, BY REGION, 2020–2027 (USD MILLION) 40

TABLE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 42

TABLE 9 GLOBAL ECLINICAL SOLUTIONS MARKET FOR WEB BASED AND CLOUD BASED, BY REGION, 2020–2027 (USD MILLION) 43

TABLE 10 GLOBAL ECLINICAL SOLUTIONS MARKET FOR ENTERPRISE BASED, BY REGION, 2020–2027 (USD MILLION) 44

TABLE 11 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 46

TABLE 12 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE I, BY REGION, 2020–2027 (USD MILLION) 46

TABLE 13 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE II, BY REGION, 2020–2027 (USD MILLION) 47

TABLE 14 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE III, BY REGION, 2020–2027 (USD MILLION) 48

TABLE 15 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHASE IV, BY REGION, 2020–2027 (USD MILLION) 49

TABLE 16 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 51

TABLE 17 GLOBAL ECLINICAL SOLUTIONS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2020–2027 (USD MILLION) 51

TABLE 18 GLOBAL ECLINICAL SOLUTIONS MARKET FOR PHARMA/BIOTECH COMPANIES, BY REGION, 2020–2027 (USD MILLION) 52

TABLE 19 GLOBAL ECLINICAL SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 55

TABLE 20 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 56

TABLE 21 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 57

TABLE 22 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 58

TABLE 23 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 58

TABLE 24 AMERICAS: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 59

TABLE 25 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 59

TABLE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 60

TABLE 27 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 61

TABLE 28 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 61

TABLE 29 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 62

TABLE 30 US: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 63

TABLE 31 US: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 64

TABLE 32 US: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 64

TABLE 33 US: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 65

TABLE 34 CANADA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 65

TABLE 35 CANADA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 66

TABLE 36 CANADA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 66

TABLE 37 CANADA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 67

TABLE 38 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 68

TABLE 39 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 69

TABLE 40 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 69

TABLE 41 LATIN AMERICA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 70

TABLE 42 EUROPE: ECLINICAL SOLUTIONS MARKET, BY REGION, 2020–2027 (USD MILLION) 71

TABLE 43 EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 72

TABLE 44 EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 73

TABLE 45 EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 73

TABLE 46 EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 74

TABLE 47 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 74

TABLE 48 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 75

TABLE 49 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 76

TABLE 50 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 76

TABLE 51 WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 77

TABLE 52 GERMANY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 77

TABLE 53 GERMANY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 78

TABLE 54 GERMANY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 78

TABLE 55 GERMANY: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 79

TABLE 56 UK: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 79

TABLE 57 UK: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 80

TABLE 58 UK: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 80

TABLE 59 UK: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 81

TABLE 60 FRANCE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 81

TABLE 61 FRANCE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 82

TABLE 62 FRANCE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 82

TABLE 63 FRANCE: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 83

TABLE 64 ITALY: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 83

TABLE 65 ITALY: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 84

TABLE 66 ITALY: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 84

TABLE 67 ITALY: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 85

TABLE 68 SPAIN: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 85

TABLE 69 SPAIN: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 86

TABLE 70 SPAIN: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 86

TABLE 71 SPAIN: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 87

TABLE 72 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 87

TABLE 73 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 88

TABLE 74 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 88

TABLE 75 REST OF WESTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 89

TABLE 76 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY TYPE, 2020–2027 (USD MILLION) 89

TABLE 77 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 90

TABLE 78 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 90

TABLE 79 EASTERN EUROPE: ECLINICAL SOLUTIONS MARKET BY END USER, 2020–2027 (USD MILLION) 91

TABLE 80 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 92

TABLE 81 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 93

TABLE 82 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 94

TABLE 83 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 94

TABLE 84 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 95

TABLE 85 JAPAN: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 95

TABLE 86 JAPAN: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 96

TABLE 87 JAPAN: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 96

TABLE 88 JAPAN: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 97

TABLE 89 CHINA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 97

TABLE 90 CHINA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 98

TABLE 91 CHINA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 98

TABLE 92 CHINA: ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 99

TABLE 93 INDIA: ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 99

TABLE 94 INDIA: ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 100

TABLE 95 INDIA: ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 100

TABLE 96 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION) 101

TABLE 97 AUSTRALIA: MARKET, BY TYPE, 2020–2027 (USD MILLION) 101

TABLE 98 AUSTRALIA: MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 102

TABLE 99 AUSTRALIA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 102

TABLE 100 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION) 103

TABLE 101 SOUTH KOREA: MARKET, BY TYPE, 2020–2027 (USD MILLION) 103

TABLE 102 SOUTH KOREA: MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 104

TABLE 103 SOUTH KOREA: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 104

TABLE 104 SOUTH KOREA: MARKET, BY END USER, 2020–2027 (USD MILLION) 105

TABLE 105 REST OF ASIA-PACIFIC: MARKET, BY TYPE, 2020–2027 (USD MILLION) 105

TABLE 106 REST OF ASIA-PACIFIC: MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 106

TABLE 107 REST OF ASIA-PACIFIC: MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 106

TABLE 108 REST OF ASIA-PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION) 107

TABLE 109 MIDDLE EAST & AFRICA: MARKET, BY REGION, 2020–2027 (USD MILLION) 108

TABLE 110 MIDDLE EAST & AFRICA: MARKET BY TYPE, 2020–2027 (USD MILLION) 109

TABLE 111 MIDDLE EAST & AFRICA: MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 109

TABLE 112 MIDDLE EAST & AFRICA: MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 110

TABLE 113 MIDDLE EAST & AFRICA: MARKET BY END USER, 2020–2027 (USD MILLION) 110

TABLE 114 MIDDLE EAST: MARKET BY TYPE, 2020–2027 (USD MILLION) 111

TABLE 115 MIDDLE EAST: MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 111

TABLE 116 MIDDLE EAST: MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 112

TABLE 117 MIDDLE EAST: MARKET BY END USER, 2020–2027 (USD MILLION) 112

TABLE 118 AFRICA: MARKET BY TYPE, 2020–2027 (USD MILLION) 113

TABLE 119 AFRICA: MARKET BY DELIVERY MODE, 2020–2027 (USD MILLION) 113

TABLE 120 AFRICA: MARKET BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 114

TABLE 121 AFRICA: MARKET BY END USER, 2020–2027 (USD MILLION) 114

15 List Of Figures

FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 MARKET ATTRACTIVENESS ANALYSIS: GLOBAL ECLINICAL SOLUTIONS MARKET 15

FIGURE 3 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY TYPE, 2020 (%) 15

FIGURE 4 GLOBAL ECLINICAL SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION) 16

FIGURE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY DELIVERY MODE, 2020 (%) 16

FIGURE 6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE, 2020–2027 (USD MILLION) 17

FIGURE 7 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE, 2020 (%) 17

FIGURE 8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE, 2020–2027 (USD MILLION) 17

FIGURE 9 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER, 2020 (%) 18

FIGURE 10 GLOBAL ECLINICAL SOLUTIONS MARKET, BY END USER, 2020–2027 (USD MILLION) 18

FIGURE 11 GLOBAL ECLINICAL SOLUTIONS MARKET: MARKET STRUCTURE 19

FIGURE 12 RESEARCH PROCESS OF MRFR 20

FIGURE 13 TOP-DOWN & BOTTOM-UP APPROACH 23

FIGURE 14 MARKET DYNAMICS: ANALYSIS OF GLOBAL ECLINICAL SOLUTIONS MARKET 24

FIGURE 15 VALUE CHAIN: GLOBAL ECLINICAL SOLUTIONS MARKET 28

FIGURE 16 PORTER'S FIVE FORCES ANALYSIS OF THE GLOBAL ECLINICAL SOLUTIONS MARKET 30

FIGURE 17 GLOBAL MARKET SHARE, BY TYPE, 2020(%) 33

FIGURE 18 GLOBAL MARKET, BY TYPE, 2020 & 2027 (USD MILLION) 34

FIGURE 19 GLOBAL MARKET SHARE, BY DELIVERY MODE, 2020 (%) 41

FIGURE 20 GLOBAL MARKET, BY DELIVERY MODE, 2020 & 2027 (USD MILLION) 42

FIGURE 21 GLOBAL MARKET SHARE, BY CLINICAL TRIAL PHASE, 2020(%) 45

FIGURE 22 GLOBAL MARKET, BY CLINICAL TRIAL PHASE, 2020 & 2027 (USD MILLION) 45

FIGURE 23 GLOBAL MARKET SHARE, BY END USER, 2020(%) 50

FIGURE 24 GLOBAL MARKET, BY END USER, 2020 & 2027 (USD MILLION) 50

FIGURE 25 GLOBAL MARKET SHARE, BY REGION, 2020(%) 54

FIGURE 26 GLOBAL MARKET, BY REGION, 2020 & 2027 (USD MILLION) 54

FIGURE 27 AMERICAS: MARKET SHARE, BY REGION, 2020 (%) 56

FIGURE 28 EUROPE: MARKET SHARE, BY REGION, 2020 (%) 71

FIGURE 29 ASIA-PACIFIC: MARKET SHARE, BY COUNTRY, 2020 (%) 92

FIGURE 30 MIDDLE EAST & AFRICA: MARKET SHARE, BY REGION, 2020 (%) 108

FIGURE 31 GLOBAL MARKET SHARE ANALYSIS, 2020 (% SHARE) 115

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Related Reports
report-img
Clinical Practice Management Software Market Research Report- Forecast To 2032
report-img
Clinical Nutrition Market Research Report - Forecast to 2032
report-img
Electronic Adhesive Market Research Report - Global Forecast till 2030
Press Release
pr-img
eClinical Solutions Market is Set to Growth at a CAGR of 12% by 2030
Logo
Dmca Cloudflare ssl
Paypal footer Ssl
Services Industry Expertise Consulting Services Articles How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners
Amex Mastercard1
Razerpay
Hdfcbank
Visa
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)

© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)